GlassScriptPhysician profile
Scott Wilson
NPI 1932858008
$16,040.04
in general payments reported to CMS, 2019-2025
9 companies · $5,932 in 2025
The $5,932 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,018 · 2023: $2,762 · 2024: $3,328 · 2025: $5,932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,460 · Food and Beverage: $4,561 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,460.03 |
| Food and Beverage | $4,560.73 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $6,373.61 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $5,409.58 | 2022-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $3,868.60 | 2023-2025 | Watchman Access System, Synergy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.38 | 2022 | |
| Penumbra, INC. | $113.61 | 2024 | Indigo System |
| Novartis Pharmaceuticals Corporation | $37.63 | 2025 | |
| Janssen Pharmaceuticals, INC | $36.49 | 2024 | Xarelto |
| W. L. Gore & Associates, INC. | $28.23 | 2025 | Gore Excluder Iliac Branch Endoprosthesis |
| Pfizer INC. | $17.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.